Drug Discovery for Leishmaniasis

Drug Discovery for Leishmaniasis PDF Author: Carmen Gil
Publisher: Royal Society of Chemistry
ISBN: 1782628894
Category : Medical
Languages : en
Pages : 422

Get Book Here

Book Description
Drug Discovery for Leishmaniasis aims to provide a perspective of the current treatments and their challenges, blended with the emerging strategies and methodologies that will drive new target appraisals and drug developments, as well as addressing the molecular basis of resistance in Leishmania.

Drug Discovery for Leishmaniasis

Drug Discovery for Leishmaniasis PDF Author: Carmen Gil
Publisher: Royal Society of Chemistry
ISBN: 1782628894
Category : Medical
Languages : en
Pages : 422

Get Book Here

Book Description
Drug Discovery for Leishmaniasis aims to provide a perspective of the current treatments and their challenges, blended with the emerging strategies and methodologies that will drive new target appraisals and drug developments, as well as addressing the molecular basis of resistance in Leishmania.

Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning

Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning PDF Author: Taís Fontoura de Almeida
Publisher: Frontiers Media SA
ISBN: 2832548997
Category : Science
Languages : en
Pages : 133

Get Book Here

Book Description
Leishmaniases are a group of tropical diseases that affect millions of people worldwide. They are considered neglected diseases prevalent in emerging countries in Latin America, West Africa, and Southeast Asia and still occurring in Mediterranean countries. There is no human vaccine available to prevent and control the disease infection. For the last 70 years, the available chemotherapy has been constituted by first-line (pentavalent antimonials) and second-line drugs (amphotericin B, pentamidine, paramomycin, and miltefosine). Its route of administration is difficult, the treatment is long, and its efficiency varies depending on the parasite species and clinical manifestations, which results in the emergence of resistant cases. Moreover, they present high toxicity to patients, and even some less toxic formulations available, are still expensive for the poorest countries’ vulnerable populations. This often leads to abandonment and failure of treatment. The medical-scientific community is facing difficulties to overcome these issues with new suitable therapies, and the identification of new drug targets. So, it means that efforts to identify new strategies must continue.

Pathogenesis, Treatment and Prevention of Leishmaniasis

Pathogenesis, Treatment and Prevention of Leishmaniasis PDF Author: Mukesh Samant
Publisher: Academic Press
ISBN: 0128227982
Category : Medical
Languages : en
Pages : 281

Get Book Here

Book Description
Leishmaniasis is a neglected tropical disease that is known to be transmitted by 90 different species of sandflies which carry 20 Leishmania species that cause human infection particularly in endemic countries. Pathogenesis, Treatment, and Prevention of Leishmaniasis aims to provide information on this vector-borne disease and explore strategies for diagnosis and treatment. The book begins with an overview of leishmaniasis which includes historical and future perspectives of the disease. It also discusses the clinical manifestation of the disease, mechanisms of infection, therapeutic strategies, diagnostics, prevention, and cure of Leishmania parasite. The book goes on to explain new insights and challenges in the development of promising drug targets, biomarkers identification and advance vaccination strategies against leishmaniasis. Chapter contributions brings together diverse areas of expertise making Pathogenesis, Treatment, and Prevention of Leishmaniasis aims to bring together elements of leishmaniasis into one place and be a valuable resource for researchers, health care professionals, and graduate students, working in the field of leishmaniasis. Provides an overview Leishmania and leishmanisis which include its history, transmission, clinical picture, and treatment Discusses novel approaches to study parasite infection and treatment Explores recent advances in the development of diagnostic kits, drug development and various vaccination strategies

Drug Resistance in Leishmania Parasites

Drug Resistance in Leishmania Parasites PDF Author: Alicia Ponte-Sucre
Publisher: Springer Science & Business Media
ISBN: 3709111250
Category : Medical
Languages : en
Pages : 458

Get Book Here

Book Description
One of the main problems concerning therapeutic tools for the treatment of parasitic diseases, including leishmaniasis, is that some field parasites are naturally resistant to the classical drugs; additionally, current therapies may select parasites prone to be resistant to the applied drugs. These features are (at least partially) responsible for the disappointing persistence of the disease and resultant deaths worldwide. This book provides a comprehensive view of the pathology of the disease itself, and of parasitic drug resistance, its molecular basis, consequences and possible treatments. Scientists both from academic fields and from the industry involved in biomedical research and drug design, will find in this book a valuable and fundamental guide that conveys the knowledge needed to understand and to improve the success in combating this disease worldwide.

Drug Discovery and Drug Development

Drug Discovery and Drug Development PDF Author: Madhu Dikshit
Publisher: Springer
ISBN: 9789811580048
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
Over the years, India has attained a prominent global position in the manufacture of Generic Drugs. This success can be attributed to its synthetic organic chemistry and chemical engineering strengths, nurtured by the timely policies of the Government of India. However, breakthrough successes in New Drug Discovery have remained elusive, despite the brilliant and sustained efforts of many Indian researchers and Pharma establishments. The Indian National Science Academy thought it appropriate to document India’s New Drug Discovery Research (NDDR) journey to date. Gathering contributions from prominent researchers in the Indian Pharma Industry and Academia, this book highlights their efforts, achievements, and the status quo of Indian NDDR.

Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis

Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis PDF Author: Gildardo Rivera
Publisher: Frontiers Media SA
ISBN: 2889717925
Category : Science
Languages : en
Pages : 171

Get Book Here

Book Description


Current Advances in Computational Strategies for Drug Discovery in Leishmaniasis

Current Advances in Computational Strategies for Drug Discovery in Leishmaniasis PDF Author: Andrés F. Flórez
Publisher:
ISBN: 9789535102748
Category :
Languages : en
Pages :

Get Book Here

Book Description


Frontiers in Anti-Infective Drug Discovery

Frontiers in Anti-Infective Drug Discovery PDF Author: Atta-ur-Rahman
Publisher: Bentham Science Publishers
ISBN: 160805912X
Category : Medical
Languages : en
Pages : 370

Get Book Here

Book Description
This ebook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the ebook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field. The third volume of this series features 6 chapters that cover a variety of topics including: - Drug Discovery for TB - Therapeutic Limitations due to Antibiotic Drug Resistance - Applications for Virus Vaccine Vectors in Infectious Disease Research - NewCastle Disease Virus - Anti-Infective Therapy Against Leishmaniasis - Anti-Viral Activity of Proanthocyanidins.

Trypanosomatid Diseases

Trypanosomatid Diseases PDF Author: Timo Jäger
Publisher: John Wiley & Sons
ISBN: 3527670408
Category : Medical
Languages : en
Pages : 850

Get Book Here

Book Description
This is the first resource to provide researchers in academia and industry with an urgently needed update on drug intervention against trypanosomatides. As such, it covers every aspect of the topic from basic research findings, via current treatments to translational approaches in drug development and includes both human and livestock diseases. The outstanding editor and contributor team reads like a Who?s Who of the field, thus guaranteeing the outstanding quality of this ready reference.

Comprehensive Analysis of Parasite Biology

Comprehensive Analysis of Parasite Biology PDF Author: Sylke Müller
Publisher: John Wiley & Sons
ISBN: 3527339043
Category : Medical
Languages : en
Pages : 574

Get Book Here

Book Description
Written and edited by experts in the field, this book brings together the current state of the art in phenotypic and rational, target-based approaches to drug discovery against pathogenic protozoa. The chapters focus particularly on virtual compounds and high throughput screening, natural products, computer-assisted drug design, structure-based drug design, mechanism of action identification, and pathway modelling. Furthermore, state-of the art "omics" technologies are described and currently studied enzymatic drug targets are discussed. Mathematical, systems biology-based approaches are introduced as new methodologies for dissecting complex aspects of pathogen survival mechanisms and for target identification. In addition, recently developed anti-parasitic agents targeting particular pathways, which serve as lead compounds for further drug development, are presented.